Structure

Physi-Chem Properties

Molecular Weight:  582.23
Volume:  604.545
LogP:  5.114
LogD:  3.872
LogS:  -4.325
# Rotatable Bonds:  10
TPSA:  136.68
# H-Bond Aceptor:  8
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.107
Synthetic Accessibility Score:  3.985
Fsp3:  0.229
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.137
MDCK Permeability:  6.75757792123477e-06
Pgp-inhibitor:  0.033
Pgp-substrate:  0.809
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.027
Plasma Protein Binding (PPB):  101.06343841552734%
Volume Distribution (VD):  0.227
Pgp-substrate:  0.6532388925552368%

ADMET: Metabolism

CYP1A2-inhibitor:  0.432
CYP1A2-substrate:  0.137
CYP2C19-inhibitor:  0.961
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.944
CYP2C9-substrate:  0.991
CYP2D6-inhibitor:  0.61
CYP2D6-substrate:  0.907
CYP3A4-inhibitor:  0.681
CYP3A4-substrate:  0.488

ADMET: Excretion

Clearance (CL):  10.874
Half-life (T1/2):  0.722

ADMET: Toxicity

hERG Blockers:  0.269
Human Hepatotoxicity (H-HT):  0.412
Drug-inuced Liver Injury (DILI):  0.751
AMES Toxicity:  0.492
Rat Oral Acute Toxicity:  0.896
Maximum Recommended Daily Dose:  0.992
Skin Sensitization:  0.959
Carcinogencity:  0.445
Eye Corrosion:  0.003
Eye Irritation:  0.878
Respiratory Toxicity:  0.542

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC15815

Natural Product ID:  NPC15815
Common Name*:   Calyxin L
IUPAC Name:   (E)-1-[(2R,4R)-5-hydroxy-4-[(2S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-2-(4-hydroxyphenyl)-7-methoxy-3,4-dihydro-2H-chromen-8-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
Synonyms:   Calyxin L
Standard InCHIKey:  WVMXLWIYDSSCRW-KBYRMXMQSA-N
Standard InCHI:  InChI=1S/C35H34O8/c1-42-32-20-30(41)33-24(18-28(39)14-6-21-2-10-25(36)11-3-21)19-31(23-8-15-27(38)16-9-23)43-35(33)34(32)29(40)17-7-22-4-12-26(37)13-5-22/h2-5,7-13,15-17,20,24,28,31,36-39,41H,6,14,18-19H2,1H3/b17-7+/t24-,28+,31-/m1/s1
SMILES:  COc1cc(c2[C@H](C[C@H](CCc3ccc(cc3)O)O)C[C@H](c3ccc(cc3)O)Oc2c1C(=O)/C=C/c1ccc(cc1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL448657
PubChem CID:   10722001
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds Mengha, Yunnan Province, China 1991-Aug PMID[11277741]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds n.a. n.a. PMID[11325233]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota Seeds n.a. n.a. PMID[11430002]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[9461664]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT453 Cell Line HT-1080 Homo sapiens ED50 = 44.3 uM PMID[545542]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 28.2 uM PMID[545542]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC15815 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC257166
0.9868 High Similarity NPC51247
0.9803 High Similarity NPC226462
0.9803 High Similarity NPC195136
0.9803 High Similarity NPC98023
0.9801 High Similarity NPC1796
0.9801 High Similarity NPC208258
0.98 High Similarity NPC79375
0.98 High Similarity NPC37253
0.9737 High Similarity NPC105584
0.9733 High Similarity NPC121568
0.9673 High Similarity NPC42965
0.9673 High Similarity NPC121647
0.9671 High Similarity NPC475184
0.9667 High Similarity NPC43345
0.96 High Similarity NPC476552
0.96 High Similarity NPC476553
0.96 High Similarity NPC178484
0.96 High Similarity NPC476551
0.9548 High Similarity NPC473012
0.9542 High Similarity NPC318527
0.9542 High Similarity NPC322459
0.9542 High Similarity NPC324358
0.9542 High Similarity NPC323627
0.9536 High Similarity NPC78324
0.9536 High Similarity NPC39154
0.9536 High Similarity NPC208011
0.9536 High Similarity NPC115601
0.949 High Similarity NPC251336
0.9487 High Similarity NPC473009
0.9484 High Similarity NPC312273
0.9484 High Similarity NPC301256
0.9477 High Similarity NPC32867
0.9477 High Similarity NPC69531
0.9477 High Similarity NPC56049
0.9477 High Similarity NPC54830
0.9474 High Similarity NPC324447
0.9467 High Similarity NPC3642
0.9427 High Similarity NPC473010
0.9416 High Similarity NPC271741
0.9416 High Similarity NPC287789
0.9412 High Similarity NPC134171
0.9412 High Similarity NPC300668
0.9412 High Similarity NPC182555
0.9412 High Similarity NPC66441
0.9408 High Similarity NPC174086
0.94 High Similarity NPC152233
0.94 High Similarity NPC122894
0.9355 High Similarity NPC295090
0.9355 High Similarity NPC51760
0.9351 High Similarity NPC61112
0.9351 High Similarity NPC198489
0.9351 High Similarity NPC309648
0.9338 High Similarity NPC132345
0.9333 High Similarity NPC475348
0.9333 High Similarity NPC261271
0.9286 High Similarity NPC158027
0.9286 High Similarity NPC215203
0.9286 High Similarity NPC14606
0.9286 High Similarity NPC100049
0.9286 High Similarity NPC159707
0.9286 High Similarity NPC205026
0.9286 High Similarity NPC258474
0.9286 High Similarity NPC52611
0.9286 High Similarity NPC121649
0.9286 High Similarity NPC248739
0.9286 High Similarity NPC265624
0.9286 High Similarity NPC201227
0.9286 High Similarity NPC186227
0.9286 High Similarity NPC150908
0.9267 High Similarity NPC470131
0.9267 High Similarity NPC228779
0.9267 High Similarity NPC109183
0.9267 High Similarity NPC470134
0.9267 High Similarity NPC470133
0.9267 High Similarity NPC473078
0.9267 High Similarity NPC470132
0.9255 High Similarity NPC477529
0.9241 High Similarity NPC63438
0.9231 High Similarity NPC123544
0.9231 High Similarity NPC90497
0.9221 High Similarity NPC290830
0.9221 High Similarity NPC71061
0.9221 High Similarity NPC194593
0.9221 High Similarity NPC303485
0.9221 High Similarity NPC72425
0.9216 High Similarity NPC316960
0.9216 High Similarity NPC148945
0.9216 High Similarity NPC204561
0.9216 High Similarity NPC317715
0.9216 High Similarity NPC78835
0.9216 High Similarity NPC309512
0.9211 High Similarity NPC473016
0.92 High Similarity NPC471523
0.92 High Similarity NPC473014
0.92 High Similarity NPC271288
0.92 High Similarity NPC473015
0.92 High Similarity NPC39045
0.92 High Similarity NPC470135
0.92 High Similarity NPC471524
0.92 High Similarity NPC473013
0.92 High Similarity NPC282957
0.92 High Similarity NPC235217
0.92 High Similarity NPC471473
0.92 High Similarity NPC470136
0.92 High Similarity NPC194949
0.92 High Similarity NPC236766
0.92 High Similarity NPC197252
0.9177 High Similarity NPC473011
0.9145 High Similarity NPC160821
0.9145 High Similarity NPC39195
0.9145 High Similarity NPC145467
0.9145 High Similarity NPC132592
0.9139 High Similarity NPC127059
0.9139 High Similarity NPC472629
0.9139 High Similarity NPC477955
0.9139 High Similarity NPC285630
0.9133 High Similarity NPC185276
0.9133 High Similarity NPC143896
0.9133 High Similarity NPC310130
0.9133 High Similarity NPC81697
0.9133 High Similarity NPC150408
0.9133 High Similarity NPC91560
0.9133 High Similarity NPC107177
0.9133 High Similarity NPC125894
0.9133 High Similarity NPC75049
0.9133 High Similarity NPC175504
0.9133 High Similarity NPC68104
0.9133 High Similarity NPC223812
0.9133 High Similarity NPC85162
0.9133 High Similarity NPC39329
0.9133 High Similarity NPC169591
0.9133 High Similarity NPC257097
0.9133 High Similarity NPC221432
0.9133 High Similarity NPC278249
0.9133 High Similarity NPC77794
0.9133 High Similarity NPC164980
0.9133 High Similarity NPC149026
0.9119 High Similarity NPC38591
0.9114 High Similarity NPC175513
0.9114 High Similarity NPC18380
0.9114 High Similarity NPC97812
0.9108 High Similarity NPC195167
0.9108 High Similarity NPC55443
0.9108 High Similarity NPC18699
0.9103 High Similarity NPC78492
0.9103 High Similarity NPC208152
0.9091 High Similarity NPC138299
0.9091 High Similarity NPC67322
0.9091 High Similarity NPC222713
0.9091 High Similarity NPC111112
0.9085 High Similarity NPC291746
0.9085 High Similarity NPC288840
0.908 High Similarity NPC168789
0.9079 High Similarity NPC283234
0.9079 High Similarity NPC308200
0.9079 High Similarity NPC10990
0.9079 High Similarity NPC296998
0.9079 High Similarity NPC23728
0.9079 High Similarity NPC110303
0.9079 High Similarity NPC473077
0.9079 High Similarity NPC300988
0.9073 High Similarity NPC87486
0.9073 High Similarity NPC209040
0.9073 High Similarity NPC470890
0.9073 High Similarity NPC131579
0.9073 High Similarity NPC124780
0.9073 High Similarity NPC131568
0.9067 High Similarity NPC324436
0.9067 High Similarity NPC194432
0.9067 High Similarity NPC223500
0.9067 High Similarity NPC66515
0.9067 High Similarity NPC328164
0.9067 High Similarity NPC182852
0.9067 High Similarity NPC306829
0.9067 High Similarity NPC228504
0.9067 High Similarity NPC125855
0.9067 High Similarity NPC296917
0.9067 High Similarity NPC202981
0.9067 High Similarity NPC64915
0.9067 High Similarity NPC324134
0.9067 High Similarity NPC40833
0.9067 High Similarity NPC166934
0.9067 High Similarity NPC177354
0.9067 High Similarity NPC161506
0.9067 High Similarity NPC148757
0.9067 High Similarity NPC37496
0.9067 High Similarity NPC167624
0.9067 High Similarity NPC107572
0.9067 High Similarity NPC1089
0.9067 High Similarity NPC227579
0.9067 High Similarity NPC78
0.9067 High Similarity NPC166482
0.9067 High Similarity NPC220998
0.9067 High Similarity NPC76338
0.9067 High Similarity NPC76372
0.9067 High Similarity NPC32739
0.9067 High Similarity NPC10937
0.9067 High Similarity NPC265040
0.9062 High Similarity NPC469664

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC15815 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9539 High Similarity NPD8443 Clinical (unspecified phase)
0.9182 High Similarity NPD7852 Clinical (unspecified phase)
0.8994 High Similarity NPD6959 Discontinued
0.8981 High Similarity NPD7768 Phase 2
0.8968 High Similarity NPD7411 Suspended
0.8947 High Similarity NPD7410 Clinical (unspecified phase)
0.8903 High Similarity NPD4380 Phase 2
0.8854 High Similarity NPD7819 Suspended
0.8805 High Similarity NPD7075 Discontinued
0.88 High Similarity NPD1549 Phase 2
0.8733 High Similarity NPD1550 Clinical (unspecified phase)
0.8733 High Similarity NPD1552 Clinical (unspecified phase)
0.8701 High Similarity NPD4378 Clinical (unspecified phase)
0.8667 High Similarity NPD7804 Clinical (unspecified phase)
0.8616 High Similarity NPD7096 Clinical (unspecified phase)
0.8616 High Similarity NPD2393 Clinical (unspecified phase)
0.8598 High Similarity NPD6166 Phase 2
0.8598 High Similarity NPD6168 Clinical (unspecified phase)
0.8598 High Similarity NPD6167 Clinical (unspecified phase)
0.8571 High Similarity NPD4381 Clinical (unspecified phase)
0.8543 High Similarity NPD2796 Approved
0.8477 Intermediate Similarity NPD1510 Phase 2
0.8438 Intermediate Similarity NPD6801 Discontinued
0.8344 Intermediate Similarity NPD3749 Approved
0.8333 Intermediate Similarity NPD1240 Approved
0.8323 Intermediate Similarity NPD1934 Approved
0.8284 Intermediate Similarity NPD7074 Phase 3
0.8258 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD5494 Approved
0.8235 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7054 Approved
0.8224 Intermediate Similarity NPD1607 Approved
0.82 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD8312 Approved
0.8198 Intermediate Similarity NPD8313 Approved
0.8176 Intermediate Similarity NPD7472 Approved
0.8171 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD7808 Phase 3
0.8118 Intermediate Similarity NPD5844 Phase 1
0.8107 Intermediate Similarity NPD7473 Discontinued
0.8089 Intermediate Similarity NPD3750 Approved
0.8081 Intermediate Similarity NPD6559 Discontinued
0.8081 Intermediate Similarity NPD7251 Discontinued
0.8067 Intermediate Similarity NPD4908 Phase 1
0.805 Intermediate Similarity NPD6799 Approved
0.805 Intermediate Similarity NPD7390 Discontinued
0.8023 Intermediate Similarity NPD6797 Phase 2
0.8012 Intermediate Similarity NPD5403 Approved
0.7987 Intermediate Similarity NPD6651 Approved
0.7978 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD6599 Discontinued
0.7953 Intermediate Similarity NPD3818 Discontinued
0.7952 Intermediate Similarity NPD3882 Suspended
0.7939 Intermediate Similarity NPD8455 Phase 2
0.7939 Intermediate Similarity NPD2801 Approved
0.7937 Intermediate Similarity NPD1511 Approved
0.7931 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD6232 Discontinued
0.7911 Intermediate Similarity NPD2800 Approved
0.7901 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD5401 Approved
0.7885 Intermediate Similarity NPD2799 Discontinued
0.7848 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD1512 Approved
0.7834 Intermediate Similarity NPD1551 Phase 2
0.7816 Intermediate Similarity NPD5953 Discontinued
0.7805 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD7458 Discontinued
0.779 Intermediate Similarity NPD4363 Phase 3
0.779 Intermediate Similarity NPD4360 Phase 2
0.7785 Intermediate Similarity NPD2344 Approved
0.7784 Intermediate Similarity NPD3817 Phase 2
0.7784 Intermediate Similarity NPD5402 Approved
0.7778 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD3748 Approved
0.7765 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD4628 Phase 3
0.7727 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD6100 Approved
0.7722 Intermediate Similarity NPD6099 Approved
0.7722 Intermediate Similarity NPD2935 Discontinued
0.7701 Intermediate Similarity NPD7286 Phase 2
0.7697 Intermediate Similarity NPD3226 Approved
0.7688 Intermediate Similarity NPD1243 Approved
0.7683 Intermediate Similarity NPD920 Approved
0.7669 Intermediate Similarity NPD2533 Approved
0.7669 Intermediate Similarity NPD2534 Approved
0.7669 Intermediate Similarity NPD2532 Approved
0.7658 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD7003 Approved
0.764 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD8151 Discontinued
0.7606 Intermediate Similarity NPD7870 Phase 2
0.7606 Intermediate Similarity NPD7871 Phase 2
0.76 Intermediate Similarity NPD1610 Phase 2
0.76 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD6832 Phase 2
0.7593 Intermediate Similarity NPD2309 Approved
0.758 Intermediate Similarity NPD5124 Phase 1
0.758 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD8150 Discontinued
0.7553 Intermediate Similarity NPD7696 Phase 3
0.7553 Intermediate Similarity NPD7698 Approved
0.7553 Intermediate Similarity NPD7697 Approved
0.75 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD5404 Approved
0.75 Intermediate Similarity NPD5408 Approved
0.75 Intermediate Similarity NPD5406 Approved
0.75 Intermediate Similarity NPD5405 Approved
0.7487 Intermediate Similarity NPD6777 Approved
0.7487 Intermediate Similarity NPD6778 Approved
0.7487 Intermediate Similarity NPD6782 Approved
0.7487 Intermediate Similarity NPD6779 Approved
0.7487 Intermediate Similarity NPD6780 Approved
0.7487 Intermediate Similarity NPD6781 Approved
0.7487 Intermediate Similarity NPD6776 Approved
0.7471 Intermediate Similarity NPD3926 Phase 2
0.7468 Intermediate Similarity NPD2798 Approved
0.746 Intermediate Similarity NPD7435 Discontinued
0.7459 Intermediate Similarity NPD4361 Phase 2
0.7459 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD2346 Discontinued
0.7443 Intermediate Similarity NPD3751 Discontinued
0.7438 Intermediate Similarity NPD7033 Discontinued
0.7435 Intermediate Similarity NPD7584 Approved
0.7414 Intermediate Similarity NPD7229 Phase 3
0.7414 Intermediate Similarity NPD3787 Discontinued
0.7412 Intermediate Similarity NPD1465 Phase 2
0.741 Intermediate Similarity NPD6273 Approved
0.7403 Intermediate Similarity NPD1203 Approved
0.7396 Intermediate Similarity NPD7701 Phase 2
0.7394 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD3268 Approved
0.7377 Intermediate Similarity NPD4287 Approved
0.7371 Intermediate Similarity NPD7801 Approved
0.7371 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7783 Phase 2
0.7365 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD8434 Phase 2
0.7356 Intermediate Similarity NPD7199 Phase 2
0.7353 Intermediate Similarity NPD7577 Discontinued
0.7345 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7177 Discontinued
0.7341 Intermediate Similarity NPD919 Approved
0.732 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7874 Approved
0.7316 Intermediate Similarity NPD6823 Phase 2
0.731 Intermediate Similarity NPD5761 Phase 2
0.731 Intermediate Similarity NPD5760 Phase 2
0.7308 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD943 Approved
0.729 Intermediate Similarity NPD2797 Approved
0.7287 Intermediate Similarity NPD7700 Phase 2
0.7287 Intermediate Similarity NPD7699 Phase 2
0.7278 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD1247 Approved
0.7251 Intermediate Similarity NPD6844 Discontinued
0.7247 Intermediate Similarity NPD7228 Approved
0.7246 Intermediate Similarity NPD7447 Phase 1
0.7246 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD8320 Phase 1
0.724 Intermediate Similarity NPD8319 Approved
0.7239 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD1548 Phase 1
0.7219 Intermediate Similarity NPD6535 Approved
0.7219 Intermediate Similarity NPD6534 Approved
0.7216 Intermediate Similarity NPD5710 Approved
0.7216 Intermediate Similarity NPD5711 Approved
0.7215 Intermediate Similarity NPD4625 Phase 3
0.7208 Intermediate Similarity NPD9717 Approved
0.7188 Intermediate Similarity NPD1613 Approved
0.7188 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7213 Phase 3
0.7186 Intermediate Similarity NPD7212 Phase 2
0.7175 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD3764 Approved
0.717 Intermediate Similarity NPD6798 Discontinued
0.7168 Intermediate Similarity NPD4288 Approved
0.7167 Intermediate Similarity NPD1729 Discontinued
0.716 Intermediate Similarity NPD7097 Phase 1
0.7159 Intermediate Similarity NPD8127 Discontinued
0.7151 Intermediate Similarity NPD37 Approved
0.7143 Intermediate Similarity NPD6355 Discontinued
0.7126 Intermediate Similarity NPD4965 Approved
0.7126 Intermediate Similarity NPD4967 Phase 2
0.7126 Intermediate Similarity NPD4966 Approved
0.7117 Intermediate Similarity NPD4308 Phase 3
0.7097 Intermediate Similarity NPD1608 Approved
0.7097 Intermediate Similarity NPD3972 Approved
0.7093 Intermediate Similarity NPD5890 Approved
0.7093 Intermediate Similarity NPD5889 Approved
0.7089 Intermediate Similarity NPD2861 Phase 2
0.7088 Intermediate Similarity NPD7685 Pre-registration
0.7088 Intermediate Similarity NPD6104 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data